SOHO 2026 Registration Now Open for Healthcare Professionals
Registration for the Fourteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2026) is officially open. This exciting event is scheduled to take place from September 9 to September 12, 2026, in Houston, Texas. Attendees can participate in-person or opt for the virtual format, ensuring accessibility for all interested participants. A special early registration rate is available for those who register by June 10, 2026, while SOHO members will enjoy an exclusive 40% discount on registration fees.
Registration Details for an Unforgettable Experience
To take advantage of the early registration rates at SOHO 2026, participants are encouraged to register promptly. Information regarding registration can be found by visiting the official SOHO website. Becoming a SOHO member is also simple and free, allowing further access to valuable resources and discounts.
Thematic Focus of SOHO 2026: Collaborative Science
This year’s meeting theme is “Advancing care through collaborative science.” According to SOHO President John DiPersio, MD, PhD, this theme comes at a critical time when research funding is dynamic and collaborative efforts across various sectors are essential. Such collaboration is vital not only for ongoing basic research but also for translating those findings into effective clinical practices, ensuring that advancements in hematology continue, despite the challenges faced in the healthcare landscape.
Plenary Talks to Enhance Learning
Attendees can look forward to three distinguished plenary talks from leading experts in the field. On Wednesday, September 9, Alan List, MD from Precision BioSciences will share his insights. On Thursday, Susan O’Brien, MD from the University of California Irvine Health will take the stage. Finally, on Friday, Neal S. Young, MD from the US National Institutes of Health will conclude the series with his presentation. These esteemed speakers will inspire the audience with innovative approaches to hematologic care.
Stay Informed About SOHO 2026
For the latest news related to SOHO 2026, interested individuals can subscribe to SOHO Insider, an essential resource for updates. Additionally, SOHO is making efforts to reach a broader audience through platforms like YouTube, enhancing communication and knowledge sharing.
Connecting with the SOHO Community
If you have any inquiries or require additional information about the SOHO Annual Meeting, contacting the organizing committee directly is encouraged. Opportunities for media sponsorship and corporate partnerships are also available, allowing organizations to engage actively with the hematology community.
A Vision for Hematology: About SOHO and SOHO Insider
The Society of Hematologic Oncology (SOHO) was established in 2012 as a nonprofit organization focused on advancing research and education in hematology. Its mission emphasizes the importance of promoting patient care and cooperation among healthcare professionals to address the complexities of hematologic malignancies. Additionally, SOHO Insider serves as the primary news outlet for the organization, launched recently to provide timely updates for healthcare practitioners in oncology and hematology.
Frequently Asked Questions
What is SOHO 2026?
SOHO 2026 is the Fourteenth Annual Meeting of the Society of Hematologic Oncology focused on advancements in hematologic care through collaborative science.
How can I register for SOHO 2026?
Registration is available on the official SOHO website, where attendees can secure their spots for the event.
What are the benefits of being a SOHO member?
SOHO members receive a significant discount on registration fees, access to exclusive resources, and opportunities to connect with fellow professionals in the field.
When is the registration deadline for early rates?
The deadline to register for early rates is June 10, 2026.
What can I expect at the event?
The event will feature plenary talks from leading experts, networking opportunities, and a platform for discussing the latest advancements in hematologic oncology.
